Cecil Richard Edmund Lyttle

Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.

MPM Acquisition Corp. was incorporated in the State of Delaware on February 4, 2008. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The company was formed as a vehicle to pursue a business combination. As such, the business purpose of the company is to seek the acquisition or merger with, an existing company. The company is headquartered in Boston, MA.

Women's Health Research Institute operates as a women’s and newborn health research center. It Its research areas include sexual, reproductive health and reproductive infectious diseases, women's cancers, maternal, fetal, and chronic diseases. The company was founded by Teresa K. Woodruff and is headquartered in Vancouver, Canada.

Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ.